Neste Stock In Focus After Bayer Winter Canola Deal
- In September 2026, Bayer AG announced a commercial deal with Neste Oyj to scale newgold winter canola across the Southern Great Plains, targeting lower carbon feedstocks for renewable diesel and sustainable aviation fuel and creating a linked outlet for high protein meal in animal feed markets.
- The newgold network and planned 2027 hybrid launch give Neste Oyj a clearer path to secure feedstock volumes from US farmers. This directly connects future biofuel output to agronomic traits like winter-hardiness, TruFlex herbicide tolerance and pod shatter resistance.
- We will now look at how Neste Oyj's investment narrative could shift as this winter canola feedstock partnership with Bayer matures.
Neste Oyj Investment Narrative Recap
To own Neste Oyj, you need to believe its renewables focus can stay relevant even if earnings forecasts point to a 1.2% annual decline over the next three years and revenue growth of 4.9% stays modest. The big short term swing factor is execution on its performance improvement program, including cost efficiencies and feedstock sourcing.
The newgold winter canola deal looks incremental rather than transformational for that near term picture. The main risk remains policy or regulatory support for renewable diesel and SAF not tracking the frameworks management is targeting, which could leave capacity additions, such as Rotterdam and debottlenecking plans, underutilized or less profitable.
The Bayer partnership plugs directly into one of Neste Oyj’s key operational levers, feedstock access. Management already positions the business as a large global buyer of inputs, and a dedicated winter canola stream in the US could help diversify volumes and support the existing performance program work on procurement and refinery optimization.
There is no separate fresh announcement beyond this agreement that meaningfully reshapes the immediate thesis, so the value sits in how it supports future capacity like Rotterdam and Singapore debottlenecking. If those assets run closer to plan, a more secure pipeline of lower carbon intensity oilseeds may help reduce input volatility and operational risk around renewable diesel and SAF output.
What The Current Forecasts Assume For Neste Oyj
Neste Oyj's current analyst framework leans on measured progress rather than a dramatic reset. Consensus views assume revenue growth of 5.9% per year over the next three years, coupled with profit margins edging from 7.4% today to 7.6% by around 2029. Earnings are modeled to move from €1.5b now to €1.9b by that 2029 window, an increase of about €400m, with a wide spread of views around that midpoint. To line up with those numbers, the shares would need to trade on a P/E of 16.3x those future earnings compared with 15.8x today, while the number of shares on issue is expected to stay broadly flat.
Neste Oyj's narrative projects €24.5b revenue and €1.9b earnings by 2029. This requires 5.9% yearly revenue growth and about €400m earnings increase from €1.5b today.
Discover why the outlook for Neste Oyj's fair value appears consistent with its current price.
Exploring Other Perspectives
You can frame this Bayer deal very differently depending on what you think about feedstock risk. The most optimistic analysts already pencilled in revenue climbing to about €28.3b and earnings near €2.1b by 2029, compared with consensus at €24.5b and €1.9b. Those views came before this agreement, so opinions may shift as the winter canola plan unfolds.
Explore 3 other Neste Oyj fair value estimates, including one that suggests as much as 93% potential upside from the current price.
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Neste Oyj research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- See our latest analysis for Neste Oyj. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Neste Oyj's overall financial health at a glance.
Looking For More Investment Ideas Beyond Neste Oyj?
If the Bayer partnership has you rethinking how feedstock security fits into the Neste Oyj story, it can help to compare that thesis with other businesses that have very different risk and return profiles. The Simply Wall St Screener lets you quickly filter for traits that matter to you, from balance sheet resilience to income potential.
- If capital preservation and steadier profiles sit high on your list, check out a hand picked 102 resilient stocks with low risk scores that score well on resilience and downside control.
- For investors who care most about financial strength and fundamental quality, start with a curated list of solid balance sheet and fundamentals (195 results) that can complement or contrast with a position in Neste Oyj.
- Income focused readers who want yield as well as business durability can review a focused 161 dividend fortresses that aim to pair higher payouts with more robust operations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com